FDA filing for retatrutide was expected from Lilly in late 2025
Also watch for reduced effectiveness at your usual dose, which may indicate potency loss
Taking too much of either medication can increase the risk of side effects, like dizziness or digestive issues
Legal documents indicate Ozempic patients have suffered serious injuries after taking the injectable prescription medication, including gastroparesis (stomach paralysis), ileus (intestinal blockage), blood clots, and vision loss
Three years later, in 2024, the FDA also approved it to reduce the risk of cardiovascular death, heart attack, and stroke for people who have obesity or overweight as well as cardiovascular disease
Licensed clinicians review intake information externally and do not interact through live visits or real-time messaging